Evidence map›Paper›PMID 31916698›Full record

ReviewJournal of cellular and molecular medicine2020

The emerging role of cellular senescence in renal diseases.

Bingru Zhou, Ying Wan, Rong Chen, Chunmei Zhang, Xuesen Li, Fanyin Meng, Shannon Glaser, Nan Wu, Tianhao Zhou, Siwen Li and 3 more

Open access · goldAbstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Deciphering the impact ofGenes & diseases · 2026
    Article
  2. Chronic Kidney Disease and Cellular Senescence.International journal of molecular sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Role of Renal Cell Senescence in Diabetic Kidney Disease: Mechanisms and Therapeutic Advances.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025
    Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Bingru ZhouDepartment of Pathophysiology, Southwest Medical University, Luzhou, China.
Ying WanDepartment of Pathophysiology, Southwest Medical University, Luzhou, China.
Rong ChenDepartment of Pathophysiology, Southwest Medical University, Luzhou, China.
Chunmei ZhangDepartment of Pathophysiology, Southwest Medical University, Luzhou, China.
Xuesen LiSchool of Basic Medical Sciences, Institute for Cancer Medicine, Southwest Medical University, Luzhou, China.
Fanyin MengRichard L. Roudebush VA Medical Center, Indiana University, Indianapolis, IN, USA.ORCID 0000-0002-7602-9091
Shannon GlaserDepartment of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX, USA.
Nan WuDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Tianhao ZhouDepartment of Medical Physiology, Texas A&M University College of Medicine, Bryan, TX, USA.
Siwen LiDepartment of Physiology, Southwest Medical University, Luzhou, China.
Heather FrancisRichard L. Roudebush VA Medical Center, Indiana University, Indianapolis, IN, USA.
Gianfranco AlpiniRichard L. Roudebush VA Medical Center, Indiana University, Indianapolis, IN, USA.
Ping ZouDepartment of Pathophysiology, Southwest Medical University, Luzhou, China.ORCID 0000-0002-0699-8487
Southwest Medical University · CNIndiana University Health · USTexas A&M University · USIndiana University School of Medicine

Funding

Autocrine/Paracrine Regulation of Intrahepatic Bile Duct GrowthI01BX000574 · VA · RLR VA MEDICAL CENTER · PI ALPINI, GIANFRANCO D · 2009 to 2022
–
Functional characters of non-coding RNAs in alcoholic liver injuryI01BX001724 · VA · RLR VA MEDICAL CENTER · PI MENG, FANYIN · 2012 to 2024
–
BLR&D Research Career Scientist AwardIK6BX004601 · VA · RLR VA MEDICAL CENTER · PI ALPINI, GIANFRANCO D · 2019 to 2025
–
BLRD VA I01 BX000574BLRD VA I01 BX001724BLRD VA IK6 BX004601
6 · The paper itself

Abstract

Cellular senescence represents the state of irreversible cell cycle arrest during cell division. Cellular senescence not only plays a role in diverse biological events such as embryogenesis, tissue regeneration and repair, ageing and tumour occurrence prevention, but it is also involved in many cardiovascular, renal and liver diseases through the senescence-associated secretory phenotype (SASP). This review summarizes the molecular mechanisms underlying cellular senescence and its possible effects on a variety of renal diseases. We will also discuss the therapeutic approaches based on the regulation of senescent and SASP blockade, which is considered as a promising strategy for the management of renal diseases.

Indexed as

AnimalsCellular SenescenceHumansKidneyKidney DiseasesPhenotypeacute renal injurycellular senescencediabetic nephropathyglomerulonephritiskidney transplanationrenal diseasesrenal fibrosissenescence-associated secretory phynotype

Identifiers

PMID31916698
PMCPMC7011136
OpenAlexW3000040610

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.